Saudi Arabia starts clinical trials to produce COVID-19 vaccine
Saudi Arabia’s Imam Abdul Rahman bin Faisal University has started the first phase of clinical trials supported by the Ministry of Education to produce a COVID-19 vaccine, after it finished the laboratory experiments and proved their effectiveness.
The move reflects the contribution of Saudi universities and their integration with the national efforts aimed at achieving the first Saudi vaccine against coronavirus, and an affirmation of the generous support that education and scientific research in the Kingdom enjoy from the leadership, local media reported.
The university has signed a contract with one of the largest specialised companies in the UK and Sweden, and worked with leading companies in the production of vaccines and medicines such as AstraZeneca, with the aim of creating appropriate quantities for use in the first phase of clinical trials.
